Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients

Table 3

Adjusted odds ratio for overall mortality according to sRAGE levels.

Model	OR (95% CI)	value
(1) Univariate	1.044 (1.009–1.083)	0.016
(2) Adjusted for age, gender, glucose, and HDL-cholesterol	1.067 (1.021–1.122)	0.006
(3) Adjusted for age, gender, glucose, HDL-cholesterol, and BNP	1.042 (0.994–1.096)	0.096

OR, odds ratio; CI, confidence interval; sRAGE, soluble receptor for advanced glycation end products. Odds ratios are for increment of 100 in the value of sRAGE. values less than 0.05 are indicated in bold.